GE’s Thaddeus Burns wrote to US Ambassador Betty King requesting US postpone Marrakesh Diplomatic Conference

Continue Reading

More notes on the India EU FTA (BTIA)

Earlier KEI published sections of the the EU India Negotiating FTA/BTIA negotiating text dealing with enforcement, along with some commentary on Article 17-31: /node/1681.

On March 28, 2013, KEI obtained another document with Article 1-5,7-8,10-33 of the negotiating next. The new text is available at /node/1691

Krista Cox will be providing her impressions here: /node/1693

Here are KEI’s quick reactions to the text.


Among the provisions in the TRIPS which protect consumers are Article 7, 8 and 40.

Continue Reading

Uncategorized

KEI letter to Steve Ricchetti, asking recusal in matters that involve former clients

On March 12, 2012, Tedmund Wan posted a note on Joe Biden’s appointment of Steve Ricchetti, exploring potential conflicts of interest with the clients in a lobbying firm that he ran. On March 29, 2012, KEI formally asked Ricchetti to recuse himself in matters concerning his former clients. The letter follows.

fullsig_t.png


29 March 2012

Steve Ricchetti
Counselor to Vice President Joe Biden
The White House
Continue Reading

Uncategorized

Who is Sally Susman, and why does she want poor people to pay higher prices for medicines?

sally_without_film_0.jpg
Sally Susman of Pfizer leads the most lethal lobbying effort on drug patents and prices. She’s also a big Obama campaign fundraiser.

For several years, Pfizer has been considered a hardliner among big pharma companies on international negotiations over intellectual property rights and drug pricing. This has not changed despite the company having had three CEOs in the past five years.

Continue Reading

Uncategorized

February 22 noon Washington, DC meeting to discuss international negotiations on copyright (With international call-in)

On Wednesday February 22, 2012, from 12:30pm to 2:30pm, KEI will host a roundtable discussion on international copyright negotiations. The location of the meeting will be 1621 Connecticut Ave, NW, Suite 500, Washington, DC 20009. There will be an opportunity to participate by telephone, via toll free calls in many countries. (To register or for details on call-in, email manon.ress@keionline.org. If you want to try to join by skype, we will do our best.)

The topics to be discussed are the following International copyright negotiations:

Continue Reading

Uncategorized

KEI files affidavit in India compulsory licensing case involving Bayer patents on cancer drug Sorafenib (Nexavar)

KEI has provided an affidavit in an India compulsory licensing dispute involving Natco and Bayer, for patents on the cancer drug sorafenib (sold by Bayer under the brand name Nexavar).

bayer_logo.gifThe Bayer price for sorafenib/Nexavar in India is $47 per 200 milligram tablet. At a daily dose of 4 tablets, this comes to $5,637 per month, or more than $68 thousand per year. In 2010, per capita income in India was $1,330.

Continue Reading

© 2024 Knowledge Ecology International. All rights reserved.
Hiero by aThemes
Burns_at_brusselsipsummit2006_60.jpg
Thaddeus Burns of GE spent months trying to derail the WIPO treaty for the blind negotiations